Vibose 0.3 Tab

2. How to take this medicine?
The medicine should be taken orally in dose of 0.2 or 0.3 g, three times daily, just before meals.

3.Who should NOT take this medication?
Voglibose is contraindicated in:

1. Hypersensitivity to the drug or to any of its components.
2. Diabetic ketoacidosis.
3. Inflammatory bowel diease, colonic ulcerations or partial intestinalobstructions and patients being predisposed to intestinal obstruction.
4. Pregnant women.

4. What side effects are possible with this medication?
Vogliboseoften causes dose-related gastrointestinal side effects such as flatulence, abdominal distension, diarrhoea, pain and hypoglycemia. A decrease in dosage and improved dietary habits may reduce these adverse effects. Hepatocellular liver damage, with jaundice and elevated serum aminotransferases may occur. Episodes of paralytic ileus in elderly diabetic patients have been reported. Intolerable dizziness with nausea and vomiting has occurred in elderly DM patients on start of therapy with Voglibose.

5. How to store Vibose^®?
Vibose^® must be kept out of the reach and sight of children. Protect from light. Store below 30°C.

6. How supplied and storage condition of Vibose^®?

• Vibose 0.2 Tablet: Box containing 30 tablets in 3X10’s blister strips. Each tablet contains voglibose INN 0.2 mg.
• Vibose 0.3 Tablet: Box containing 30 tablets in 3X10’s blister strips. Each tablet contains voglibose INN 0.3 mg.
• Vibose® must be kept out of the reach and sight of children. Protect from light. Store below 30°C.

Vibose Prescribing Information